DJIA 16,950.85 31.26 0.18%
NASDAQ 4,527.57 0.05 0.00%
S&P 500 1,983.68 2.08 0.10%
market minute promo

GlaxoSmithKline (NYSE: GSK)

47.61 0.26 (0.55%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $47.61 0.55%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.48
Previous Close $47.35
Daily Range $47.30 - $47.62
52-Week Range $46.01 - $56.73
Market Cap $114.4B
P/E Ratio 16.27
Dividend (Yield) $2.59 (5.6%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,901,104
Average Daily Volume 4,295,311
Current FY EPS $3.20





GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary Rss Feed

3 Reasons GlaxoSmithKline plc Stock Could Rise

GlaxoSmithKline's transition period has been far rougher than expected, causing shares to drop nearly 15% last quarter. Even so, there are three compelling reasons to believe that shares could rally heading into the end of the year.

Eurozone Recovery Stalls in Q2: 3 Stocks to Sell Now - Analyst Blog

If You Want Dividend Income, Look No Further than GlaxoSmithKline plc Stock

GlaxoSmithKline's focus on these two therapeutic areas could be the impetus that pushes its payout higher and puts ample dividend income in shareholders' pockets.

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

GlaxoSmithKline: To Buy Or Not To Buy?

Kindred 30.33% Upside Paced Healthcare August Dividend Dogs

Sinopharm, Biostar, Lilly Rise on Medical Modernization in China

Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

Ebola Vaccine and Inhaled Insulin Incoming

Biotech partnerships, an IPO that wasn't, and how big data is fighting Ebola.

Why GlaxoSmithKline Is A Tempting Buy

See More GSK News...

GSK's Top Competitors

GSK $47.61 (0.55%)
Current stock: GSK
JNJ $103.06 (0.10%)
Current stock: JNJ
NVS $88.89 (0.29%)
Current stock: NVS
RHHBY $36.54 (-0.29%)
Current stock: RHHBY